Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol von THOMAS, James P, TUTSCH, Kendra D, DRESEN, Amy, WILDING, George, CLEARY, James F, BAILEY, Howard H, ARZOOMANIAN, Rhoda, ALBERTI, Dona, SIMON, Kris, FEIERABEND, Chris, BINGER, Kimberly, MARNOCHA, Rebecca

Volltext

Phase I Clinical and Pharmacokinetic Study of Perillyl Alcohol Administered Four Times a Day von RIPPLE, G. H, GOULD, M. N, MARNOCHA, R, WILDING, G, BAILEY, H. H, ARZOOMANIAN, R. Z, ALBERTI, D, FEIERABEND, C, SIMON, K, BINGER, K, TUTSCH, K. D, POMPLUN, M, WAHAMAKI, A

Volltext

Phase I Clinical and Pharmacokinetic Study of NSC 655649, a Rebeccamycin Analogue, Given in Both Single-Dose and Multiple-Dose Formats von MERCHANT, Joseph, TUTSCH, Kendra, WILDING, George, DRESEN, Amy, ARZOOMANIAN, Rhoda, ALBERTI, Dona, FEIERABEND, Chris, BINGER, Kim, MARNOCCHA, Rebecca, THOMAS, James, CLEARY, Jim

Volltext

Phase I trial of perillyl alcohol administered four times daily continuously von MORGAN-MEADOWS, Sherry, DUBEY, Sarita, ELLINGEN, Shawna, BLACK, Sandra, POMPLUN, Marcia, WILDING, George, BAILEY, Howard, GOULD, Michael, TUTSCH, Kendra, MARNOCHA, Rebecca, ARZOOMANIN, Rhoda, ALBERTI, Dona, BINGER, Kimberly, FEIERABEND, Chris, VOLKMAN, Jennifer

Volltext

Phase I clinical and pharmacokinetic trial of irofulven von THOMAS, James P, ARZOOMANIAN, Rhoda, MACDONALD, John, WILDING, George, BAILEY, Howard, ALBERTI, Dona, FEIERABEND, Chris, BINGER, Kimberly, TUTSCH, Kendra D, STEELE, Thomas, MARNOCHA, Rebecca, SMITH, Charlotte, SMITH, Sheri

Volltext

Phase I Clinical and Pharmacokinetic Study of Oral Penclomedine (NSC 338720) in Adults with Advanced Solid Malignancy von LIU, Glenn, BERLIN, Jordan, WILDING, George, TUTSCH, Kendra D, VAN UMMERSEN, Lynn, DRESEN, Amy, MARNOCHA, Rebecca, ARZOMANIAN, Rhoda, ALBERTI, Dona, FEIERABEND, Chris, BINGER, Kimberly

Volltext

A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors von BERLIN, J. D, ALBERTI, D. B, ARZOOMANIAN, R. Z, FEIERABEND, C. A, SIMON, K. J, BINGER, K. A, MARNOCHA, R. M, WILDING, G

Volltext

Phase I Study of Continuous-Infusion l-S,R-Buthionine Sulfoximine With Intravenous Melphalan von Bailey, Howard H., Ripple, Greg, Tutsch, Kendra D., Arzoomanian, Rhoda Z., Alberti, Dona, Feierabend, Chriss, Mahvi, David, Schink, Julian, Pomplun, Marcia, Mulcahy, R. Timothy, Wilding, George

Volltext

Phase I Trial of Intravenous Thymidine and Carboplatin in Patients With Advanced Cancer von ROBINS, H. I, TUTSCH, K, FEIERABEND, C, WILDING, G, KATSCHINSKI, D. M, JACOBSON, E, MEHTA, M, OLSEN, M, COHEN, J. D, TIGGELAAR, C. L, ARZOOMANIAN, R. Z, ALBERTI, D

Volltext

Phase I clinical trial of perillyl alcohol administered daily von RIPPLE, G. H, GOULD, M. N, STEWART, J. A, TUTSCH, K. D, ARZOOMANIAN, R. Z, ALBERTI, D, FEIERABEND, C, POMPLUN, M, WILDING, G, BAILEY, H. H

Volltext

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer von SCHILLER, J. H, STORER, B, TUTSCH, K, ARZOOMANIAN, R, ALBERTI, D, FEIERABEND, C, SPRIGGS, D

Volltext

A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days von BAILEY, Howard H, WILDING, George, LEWIS, Kriste A, HOHL, Raymond J, TUTSCH, Kendra D, ARZOOMANIAN, Rhoda Z, ALBERTI, Dona, FEIERABEND, Chris, SIMON, Kris, MARNOCHA, Rebecca, HOLSTEIN, Sarah A, STEWART, Jan

Volltext

Phase I and pharmacokinetic study of a Micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: Toxicity, bioavailability and the effect of food von BERLIN, Jordan, TUTSCH, Kendra D, ARZOOMANIAN, Rhoda Z, ALBERTI, Dona, BINGER, Kim, FEIERABEND, Chris, DRESEN, Amy, MARNOCHA, Rebecca, PLUDA, James, WILDING, George

Volltext

Phase I trial of the polyamine analog N1,N14-diethylhomospermine (DEHSPM) in patients with advanced solid tumors von Wilding, George, King, David, Tutsch, Kendra, Pomplun, Marcia, Feierabend, Chris, Alberti, Dona, Arzoomanian, Rhoda

Volltext

Phase I clinical trial of carboplatin and 41.8°C whole-body hyperthermia in cancer patients von ROBINS, H. I, COHEN, J. D, RUSHING, D, LOVE, R, SPRIGGS, D, SCHMITT, C. L, TUTSCH, K. D, FEIERABEND, C, ARZOOMANIAN, R. Z, ALBERTI, D, D'OLEIRE, F, LONGO, W, HEISS, C

Volltext

Phase I and Pharmacokinetic Study of a Micronized Formulation of Carboxyamidotriazole, a Calcium Signal Transduction Inhibitor von Jordan Berlin, Kendra D. Tutsch, Rhoda Z. Arzoomanian, Dona Alberti, Kim Binger, Chris Feierabend, Amy Dresen, Rebecca Marnocha, James Pluda, George Wilding

Volltext

Phase I study of docetaxel and topotecan in patients with advanced malignancies von Dubey, Sarita, Hutson, Paul, Alberti, Dona, Arzoomanian, Rhoda, Binger, Kim, Volkman, Jennifer, Feierabend, Chris, Wilding, George, Schiller, Joan H

Volltext

Gemcitabine, paclitaxel, and piritrexim: A phase I study von LIU, Glenn, BAILEY, Howard H, ARZOOMANIAN, Rhoda Z, ALBERTI, Dona, BINGER, Kimberly, VOLKMAN, Jennifer, FEIERABEND, Chris, MARNOCHA, Rebecca, WILDING, George, THOMAS, James P

Volltext

Phase I study of eniluracil, oral 5-fluororacil and gemcitabine in patients with advanced malignancy von MORGAN-MEADOWS, Sherry, THOMAS, James P, ARZOOMANIAN, Rhoda Z, WILDING, George, MULKERIN, Daniel, BERLIN, Jordan D, BAILEY, Howard, BINGER, Kim, VOLKMAN, Jennifer, ALBERTI, Dona, FEIERABEND, Chris, MARROCHA, Rebecca

Volltext

Phase I clinical and pharmacokinetic trial of penclomedine using a novel, two-stage trial design for patients with advanced malignancy von BERLIN, J, STEWART, J. A, STORER, B, TUTSCH, K. D, ARZOOMANIAN, R. Z, ALBERTI, D, FEIERABEND, C, SIMON, K, WILDING, G

Volltext